C07K 14/31
From staphylococcus
Official title: from Staphylococcus (G)
C07K14/31 (From staphylococcus) appears on 830 US grants and 942 published applications in this corpus.
Search patents in C07K- Granted patents
- 830
- Published applications
- 942
- Assignees
- 424
- Inventors
- 1,742
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 4 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 11 | 0 |
| 1993 | 8 | 0 |
| 1994 | 6 | 0 |
| 1995 | 7 | 0 |
| 1996 | 10 | 0 |
| 1997 | 13 | 0 |
| 1998 | 26 | 0 |
| 1999 | 38 | 0 |
| 2000 | 46 | 0 |
| 2001 | 54 | 1 |
| 2002 | 32 | 39 |
| 2003 | 23 | 49 |
| 2004 | 25 | 32 |
| 2005 | 12 | 41 |
| 2006 | 17 | 27 |
| 2007 | 17 | 44 |
| 2008 | 19 | 21 |
| 2009 | 14 | 31 |
| 2010 | 28 | 55 |
| 2011 | 19 | 33 |
| 2012 | 24 | 39 |
| 2013 | 27 | 33 |
| 2014 | 26 | 37 |
| 2015 | 22 | 39 |
| 2016 | 30 | 42 |
| 2017 | 26 | 39 |
| 2018 | 29 | 39 |
| 2019 | 34 | 47 |
| 2020 | 33 | 39 |
| 2021 | 30 | 42 |
| 2022 | 20 | 37 |
| 2023 | 29 | 43 |
| 2024 | 21 | 42 |
| 2025 | 25 | 26 |
| 2026 | 13 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Staphylococcus aureus vaccine compositions15 Sep 2026US 12,734,227 B2New York University
- Recombinant bacteria and uses thereof18 Aug 2026US 12,708,650 B2National University of Singapore
- Methods and compositions for treating skin disease with recombinant microorganisms11 Aug 2026US 12,702,684 B2Azitra Inc
- Antimicrobial therapy11 Aug 2026US 12,702,686 B2The Regents of the University of California
- Alkali-tolerant affinity chromatography ligands14 Jul 2026US 12,679,873 B2Guangzhou Binding Technologies Co., Limited
- Methods and compositions comprising staphylococcus protein a (spa) variants24 Sep 2026US 2026/0284169 A1The University of Chicago
- Antagonists of human fgf2317 Sep 2026US 2026/0274901 A1
- Modified biotin-binding protein, fusion proteins thereof and applications10 Sep 2026US 2026/0265313 A1Children's Medical Center Corporation
- Materials and Methods For Cell-Free Expression of Vaccine Epitope Concatemers27 Aug 2026US 2026/0250332 A1Leidos, Inc.
- Inhibitors of il11ra based signalling13 Aug 2026US 2026/0234199 A1
Most cited
By later US patents
- Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling242US 5,811,097 AThe Regents of the University of California · 1998
- Bacterial receptor structures188US 5,831,012 APharmacia & Upjohn Aktiebolag · 1998
- Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories181US 5,994,066 AInfectio Diagnostic, Inc. · 1999
- Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories178US 6,001,564 AInfectio Diagnostic, Inc. · 1999
- Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling161US 6,051,227 AThe Regents of the University of California Office of Technology Transfer · 2000